Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Croatia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20082
20092
20101
20131
20141
20154
20163
20171
20192
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Boehringer Ingelheim2
EMD Serono Research & Development Institute, Inc.2
NovoCure GmbH2
AbbVie1
Amgen1
AstraZeneca1
Centus Biotherapeutics Limited1
Helsinn Healthcare SA1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung22
Lung Neoplasms3
Neoplasms3
Anemia1
Brain Neoplasms1
Cachexia1
Neoplasm Metastasis1
Pleural Effusion1
Pleural Effusion, Malignant1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.